ANKTIVA®
Clinical Trials
Find a Trial
Become a Trial
Investigator
License our Cells
Science
Platforms
Pipeline
Expanded Access
Research
Approach
Patients
Trial Investigators
Researchers
Condition
Bladder Cancer
Glioblastoma
Lynch / Colon Cancer
Non-Small Cell Lung Cancer
HIV
Company
About Us
Investors
News
Contact
Careers
Founder’s Vision
Cancer Moonshot 2020
Childhood Cancer – Sen. McCain
Cancer Moonshot Announcement
Formation of ImmunityBio
Select Page
Acceptance Requirements
Adult patients diagnosed with HIV-1 infection
Must have been on ART for at least 96 weeks prior to joining the trial
Search for:
Recent Posts
Bladder Cancer Advocacy Network Think Tank
LUGPA 2024 Annual Meeting
Bladder Cancer Advocacy Network Patient Summit
H.C. Wainwright 26th Annual Global Investment Conference
ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors